Navigation Links
LSTM-Eisai-UoL awarded GHIT Fund to deliver anti-Wolbachia drug discovery
Date:3/20/2014

dvanced rounds of chemical modification and testing to identify lead candidate compounds that have a good safety and efficacy profiles ready to move into pre-clinical testing.

With tropical disease expertise led by Prof Steve Ward and Prof Mark Taylor based at LSTM, chemical optimisation of analogues will be performed at Eisai in collaboration with Prof Paul O'Neill's laboratory at the Department of Chemistry, UoL. This unique partnership brings together internationally recognised drug discovery expertise focusing on a novel approach to address the current challenges of two parasitic diseases that affect the lives of many millions of people globally.


'/>"/>

Contact: Clare Bebb
c.bebb@liv.ac.uk
44-015-170-53135
Liverpool School of Tropical Medicine
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Kessler Foundation MS scientist awarded Patterson Trust Award in Clinical Research
2. Sloan Research Fellowships awarded to 126 young scholars
3. Director of Womens Guild Lung Institute awarded grant to study treatment for lung disease
4. UC Irvine stem cell researchers awarded $1.54 million in state funding
5. IU School of Medicine researchers awarded $300,000 GE/NFL grant to study concussions
6. UTSA/UTHSCSA awarded $900,000 to prevent substance abuse and HIV/AIDS transmission
7. Mass. Eye and Ear physician awarded RPB Career Development Award
8. Researchers awarded grant from the DeGregorio Family Foundation
9. Obesity Solutions Mexico Directed by Dr. Jose A. Castaneda Awarded 2013's Best Bariatric Surgeon by allPrivateHealth.com
10. Family Voices Awarded Project to Fight Childhood Obesity by the Patient-Centered Outcomes Research Institute
11. Population Council awarded USAID cooperative agreement to develop non-antiretroviral HIV microbicide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2015)... (PRWEB) March 01, 2015 Theme and ... new transition pack for Final Cut Pro ... accordion style transitions to any FCPX editors project.” Said ... our users the tools needed to easily drag and ... The user gets many different controls over the parameters ...
(Date:2/28/2015)... Heart diseases are on the rise in ... adult population and 5 percent of rural adult population ... percent of them require specialized investigation and treatment to ... diseases (CVD). , A division of Indian Business News ... titled “Indian Coronary Stent Market Forecast to 2019”. The ...
(Date:2/28/2015)... 28, 2015 The Heart Fit Clinic ... distributor of the machine. The Heart Fit Clinic is ... like a franchise model. The goal is to scale ... heart disease. To buy External Counterpulsation machines ... help individuals through this process and achieve the desired ...
(Date:2/28/2015)... Vancouver, BC (PRWEB) February 28, 2015 Vancouver ... several personal injury claims are affected by time limits. They ... can weaken a person’s claim or even nullify it. Many ... adverse effects on a client’s rights under BC law. As ... who are affected by accidents should consult a personal injury ...
(Date:2/28/2015)... MD (PRWEB) February 28, 2015 The ... present its annual awards at the International Symposium on ... will be held at the Hyatt Regency Bethesda in ... for their dedicated work and commitment to the mission ... the Year Award will be presented to Miriam Ratner. ...
Breaking Medicine News(10 mins):Health News:Announcing a New Transition Pack from Pixel Film Studios, Transccordion for Final Cut Pro X 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 3Health News:Clinicians Can Now Purchase External Counterpulsation with Heart Fit Clinic 2Health News:Jiwa Law Corporation Recently Announced That Time Delays May Weaken Personal Injury Claims 2Health News:Cancer Research Foundation Honors Award Recipients 2Health News:Cancer Research Foundation Honors Award Recipients 3Health News:Cancer Research Foundation Honors Award Recipients 4
... , TUCSON, Ariz., Nov. 25 ... ) today announced that its LogistiCare subsidiary, the nation,s ... notice of award from the State of Florida Commission ... services to both Miami-Dade and Volusia Counties. The ...
... , LOS ANGELES, Nov. 25 Hair Fairies, ... www.hairfairies.com ), announced that it will ring in the holiday season ... the Head Lice Hotline at 1-877-285-0069 will receive their choice of ... addition, Hair Fairies will offer 50% off its whole range of ...
... LAKE, N.J., Nov. 25 Par Pharmaceutical Companies, Inc. (NYSE: ... "Modified Dutch Auction" tender offer, in which Par offered to ... up to approximately 82.7%, of its outstanding 2.875% Senior Subordinated ... American Stock Transfer & Trust Company, LLC, the depositary for ...
... animal study , WEDNESDAY, Nov. 25 (HealthDay News) -- ... as some synthetic drugs, English researchers report. , Traditional ... Hyptis crenata to treat a range of health ... study is the first to scientifically prove the pain-relieving ...
... ... technology for treating chronic sinus inflammation is available at Baptist Medical Center in Jackson, ... quickly open and expand blocked sinuses. , ... (Vocus) November 25, 2009 -- A clinically proven, minimally invasive ...
... ... of cavities and the glamour of smile makeovers. In fact, it is looking ... and beauty of teeth is what the public expects form dentistry, we know ... team. The increasingly important link between oral and systemic health is being strengthened ...
Cached Medicine News:Health News:Providence Service Corporation's LogistiCare Subsidiary Announces Non-Emergency Medical Transportation Contracts Worth Over $11 Million Annually in Florida 2Health News:Providence Service Corporation's LogistiCare Subsidiary Announces Non-Emergency Medical Transportation Contracts Worth Over $11 Million Annually in Florida 3Health News:Hair Fairies Kicks Off the Holiday Season With an All Natural Head Lice Product Giveaway 2Health News:Hair Fairies Kicks Off the Holiday Season With an All Natural Head Lice Product Giveaway 3Health News:Par Pharmaceutical Announces Results of Its 'Modified Dutch Auction' Tender Offer 2Health News:Novel Technology in Treating Chronic Sinus Infections Available at Baptist 2Health News:Novel Technology in Treating Chronic Sinus Infections Available at Baptist 3Health News:Local Dentist Teaches Other Dentists How to Save the Lives of Their Patients 2Health News:Local Dentist Teaches Other Dentists How to Save the Lives of Their Patients 3
(Date:2/27/2015)... The role of the Medical Science Liaison ... hasn,t changed: face-to-face meetings are seen as the best ... Leaders. Yet at the same time face-to-face ... interaction, field medical teams within the pharmaceutical sector are ... just one of the challenges addressed in " Medical ...
(Date:2/27/2015)... SUNNYVALE, Calif. , Feb. 27, 2015 /PRNewswire/ ... highlighted findings from a pre-clinical study published in ... Sciences ( www.pnas.org/cgi/doi/10.1073/pnas.1500712112 ) that showed when ... anti-PD-L1 antibody (a checkpoint inhibitor), suppression of tumor ... be achieved when treating certain hematologic cancers and ...
(Date:2/27/2015)... 27, 2015 ... sistema di monitoraggio dell,infarto congestizio (CHF - Congestive ...     Vectorious Medical ... sistema per il monitoraggio cardiaco destinato a pazienti ... di aver concluso una raccolta di finanziamenti per ...
Breaking Medicine Technology:Improving the Management of MSL Teams to Create Value across a Diverse Set of Customers 2In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 2In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 3In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 4In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 5In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 6In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 7In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 8In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 9Vectorious Medical Technologies completa una raccolta di 5 milioni di dollari 2
... 2011  Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) announces ... Pipeline  When: , Thursday, December 15, 2011 ... Where: , www.isispharm.com  How: , Live ... above.  Contacts: , Kristina Lemonidis  , Director, ...
... the MarginProbe pivotal study were presented today during ... The results were presented by Dr. Freya Schnabel, ... New York University, New York, New York.  In ... MarginProbe significantly improved surgical outcomes by improving surgeons, ...
Cached Medicine Technology:MarginProbe® Pivotal Study Presented at San Antonio Breast Cancer Symposium 2
... advanced magnetoencephalography (MEG) device providing real-time mapping ... magnetic fields produced by the brain. , ... most sophisticated MEG/EEG devices available on the ... the sensors combined with advanced software makes ...
... 2500 WH , with its large array ... coverage allowing the localization of activity throughout ... resolution and millimeter spatial resolution. Featuring an ... database and rapid data processing and display, ...
... be used for demonstration and training in: ... , ,The Model Practice Eye is ... the human eye size and shape and the ... lens and pupil arrangement simulate the optics of ...
... With multiple wall stand and table configurations ... radiography applications, Canon CXDI-40G can capture 17 ... position or angle. This flexible system includes ... universal stand, and a ceiling suspended multi-positioning ...
Medicine Products: